LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.

robot
Abstract generation in progress

LIR Life Sciences Corp. has entered into a Technology Development Collaboration Agreement with Resilience BioSciences Inc. to support and expand LIR’s preclinical research activities. This collaboration will involve LIR conducting early-stage experimental work at RBI’s state-of-the-art facilities located at the University of British Columbia, leveraging the academic environment and experienced scientific teams for efficient and cost-effective study progression. LIR will pay RBI $5,000 per month for an initial six-month term, with potential for future application of LIR’s delivery technology in RBI’s own development programs.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin